Literature DB >> 12942192

[Exanthema simulating measles without measles virus? Allergic reaction to a non-nucleoside reverse transcriptase inhibitor in an HIV infected boy treated with HAART].

G-M Lackmann1, B Schmidt, T Niehues.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12942192     DOI： 10.1007/s00105-003-0567-5

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  7 in total

Review 1.  Childhood exanthems: a primer and update for the dermatologist.

Authors:  A J Mancini
Journal:  Adv Dermatol       Date:  2000

2.  Nevirapine-associated Stevens-Johnson syndrome.

Authors:  K J Warren; D E Boxwell; N Y Kim; B A Drolet
Journal:  Lancet       Date:  1998-02-21       Impact factor: 79.321

Review 3.  Measles: not just another viral exanthem.

Authors:  Trevor Duke; Charles S Mgone
Journal:  Lancet       Date:  2003-03-01       Impact factor: 79.321

4.  Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy.

Authors:  A Antinori; F Baldini; E Girardi; A Cingolani; M Zaccarelli; S Di Giambenedetto; A Barracchini; P De Longis; R Murri; V Tozzi; A Ammassari; M G Rizzo; G Ippolito; A De Luca
Journal:  AIDS       Date:  2001-08-17       Impact factor: 4.177

5.  Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions.

Authors:  N Yawalkar; F Egli; Y Hari; H Nievergelt; L R Braathen; W J Pichler
Journal:  Clin Exp Allergy       Date:  2000-06       Impact factor: 5.018

Review 6.  Severe measles in immunocompromised patients.

Authors:  L J Kaplan; R S Daum; M Smaron; C A McCarthy
Journal:  JAMA       Date:  1992-03-04       Impact factor: 56.272

Review 7.  Human herpesvirus 6 and human herpesvirus 7: emerging pathogens in transplant patients.

Authors:  Duncan A Clark
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.319
  7 in total
  1 in total

1.  [Rashes in HIV-infected patients undergoing therapy with nevirapine or efavirenz].

Authors:  M Hartmann; J Brust; D Schuster; F Mosthaf; M Procaccianti; J A Rump; H Klinker; D Petzoldt
Journal:  Hautarzt       Date:  2005-09       Impact factor: 0.751
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.